Diazoxide, however, is ineffective in approximately half of all CHI patients because its mechanism of action depends on a functional KATP channel, which is impaired by the most common mutations ...
Diazoxide is an antihypertensive, nondiuretic benzothiadiazine with a potent hyperglycemic action. The latter property ... hyperglycemia by nonpancreatic mechanisms as well.